JPM 2026: From "Recovery" to "Execution"
The "growth at all costs" era is officially dead. The vibe at the 44th Annual J.P. Morgan Healthcare Conference was one of cautious optimism. The industry has pivoted from scrambling for procedure volume recovery to a disciplined focus on operating margins, supply chain stability, and execution.
If 2025 was about stabilization, 2026 is about the "Boring Breakthrough"—where success isn't defined by sci-fi concepts, but by workflow efficiency and profitability.
The Big 3 Trends
1. The "Agentic AI" Era We’ve moved past AI that merely analyzes data to AI that acts.
The Shift: From "Smart Implants" to "Workflow Automation."
The News: Tech that drafts surgical plans for approval and automates back-office revenue cycles.
The Takeaway: If your tech adds administrative burden, it’s dead on arrival. The winning value prop for 2026 is removing friction for ASC staff and surgeons.
2. The ASC "Land Grab" is Structural The migration to ASCs is no longer a trend; it’s the default reality.
The Shift: Capital equipment must fit 400-square-foot ORs. "ASC-ready" (modular, instrument-free) is the new standard.
The News: Commercial models are evolving toward ...
